Drug Profile
Fexofenadine hydrochloride - 3SBio
Latest Information Update: 11 Dec 2021
Price :
$50
*
At a glance
- Originator 3SBio
- Class Acetic acids; Antiallergics; Antihistamines; Benzhydryl compounds; Nonsedating antihistamines; Piperidines; Small molecules
- Mechanism of Action Histamine H1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Allergic rhinitis; Urticaria
Most Recent Events
- 28 Feb 2019 No recent reports of development identified for phase-I development in Allergic-rhinitis in China (PO, Tablet)
- 28 Feb 2019 No recent reports of development identified for phase-I development in Urticaria in China (PO)